—CL
— • —
$84.34
P/E
32.17
PEG
—
FCF Yield
—
Rev Growth YoY
+140.0% YoY
Gross Margin
6011.0%
Health Score
3/10
D/E Ratio
147.93
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits full contextual framing. Based on available data, this appears to be a company generating meaningful revenue with a current share price of $84.34. The extreme valuation ratios — particularly a Price/Book of 1,179.54x and a Return on Equity of 43,159% — suggest a highly asset-light or financially unusual business structure that warrants careful scrutiny.
Financial Health
**Score: 3/10** The financial health picture is deeply conflicted. On the surface, a reported gross margin of 6,011% and net margin of 1,046% appear extraordinary, but these figures are almost certainly the result of unusual accounting items, one-off gains, or data anomalies — and should not be taken at face value without further verification...
Risk Assessment
- **DEBT:** Debt/Equity of 147.93x is extreme by any standard, creating substantial refinancing and solvency risk under adverse conditions. - **LIQUIDITY:** Current ratio of 0.83x means short-term liabilities exceed short-term assets, indicating potential near-term cash flow stress. - **EARNINGS COLLAPSE:** Earnings growth of -2,535% YoY directly contradicts the strong revenue trend, suggesting structural cost or write-down issues. - **DATA INTEGRITY:** Gross margin of 6,011% and ROE of 43,159% are implausible as operating metrics and suggest either accounting anomalies or data errors that undermine the reliability of the financial picture. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) with price below both moving averages signals sustained negative price momentum. ---...